FNO Stocks

Tata Power Ltd. Share Analysis 2026: Bullish & Bearish View, Fundamentals, Growth Outlook and 5-Year Price Target

by
tata power

[et_pb_section][et_pb_row][et_pb_column type=”4_4″][et_pb_text] Tata Power – Building India’s Energy Future Tata Power Ltd. is one of India’s oldest and most diversified power companies. Over the past decade, it has evolved from a traditional electricity producer into a company focused on renewable energy, solar manufacturing, power distribution, electric vehicle (EV) charging infrastructure, and clean-energy solutions. India’s rising … Read more

How to Pick Bullish or Bearish F&O Stocks Using Pre-Open Market Data

by
Pre-Open Data to Pick Bullish & Bearish F&O Stocks

The 9:00 AM–9:08 AM pre-open session can provide useful clues about market sentiment, but it should be treated as an indication rather than a guarantee. Combining pre-open data with futures and options data generally gives more reliable trade ideas. ✅ Step 1: Check Nifty & Bank Nifty Pre-Open Bullish Market Nifty pre-open +0.50% or more … Read more

Adani Power Ltd – Bullish & Bearish Analysis Price Target

by
Adani Power

🟢 Bullish Analyst Opinions 1. India’s Largest Private Thermal Power Producer Adani Power continues to benefit from rising electricity demand driven by industrialization, manufacturing, electric vehicles, and data centers. 2. Strong Power Demand Outlook India’s power consumption is expected to grow steadily over the next decade, supported by economic growth, infrastructure expansion, and increasing electrification. … Read more

Polycab India Ltd. – Detailed Bullish & Bearish Analyst Opinions with Price Target

by
Polycab India Ltd.

Overall Analyst Consensus Consensus Rating: Buy Analysts Covering: 31 Buy: 22 Hold: 8 Sell: 1 Average 12-Month Target: ~₹9,530 Highest Target: ₹11,950 Lowest Target: ₹6,490 POLYCAB INDIA FINANCIAL DATA OUTLOOK 🟢 Bullish Analyst Opinions 1. Market Leader in Wires & Cables Polycab remains India’s largest wires and cables manufacturer, benefiting from strong demand across housing, … Read more

Biocon Ltd – bullish and bearish analyst opinions With Price Target

by
biocon shares

🟢 Bullish Factors 1. Global Biosimilars Leader Biocon is among the world’s leading biosimilar manufacturers with products marketed across the United States, Europe, and emerging markets. The company has more than 30 biosimilars in its portfolio and continues expanding globally. 2. Weight-Loss Drug Opportunity One of the biggest growth drivers is Biocon’s planned rollout of … Read more

Divi’s Laboratories Ltd. – Bullish & Bearish Analyst Opinions (2026)

by
Divi's Laboratories shares

Overall Analyst Consensus Consensus Rating: Neutral to Outperform Analysts Covering: 30 Buy: 15 Hold: 6 Sell: 9 Average 12-Month Target: ₹7,089 Highest Target: ₹9,450 Lowest Target: ₹5,610 🟢 Bullish Analyst Opinions 1. Strong CRAMS/CDMO Growth Divi’s Laboratories is one of India’s leading Contract Research, Development & Manufacturing (CRDMO) companies. Analysts expect increasing outsourcing by global … Read more

Hero MotoCorp Ltd. – Bullish & Bearish Analyst Opinions

by
Hero MotoCorp shares

Overall Analyst Consensus Consensus Rating: Buy / Moderately Bullish Average Analyst Target: ~₹5,900 Expected Upside: Around 20% from recent trading levels, based on aggregated analyst estimates. 🟢 Bullish Analyst Opinions 1. Strong Rural Demand Recovery Analysts expect improving rural incomes, a favorable monsoon, and continued replacement demand to support motorcycle sales over the coming years. … Read more

JSW Energy (NSE: JSWENERGY) Bullish & Bearish Fundamental Analysis

by
JSW Energy

Key Fundamentals Snapshot (approx. values as of early July 2026) Current Price: ~₹530–545 Market Cap: ~₹98,000–100,000 Cr Stock P/E (TTM): 42–46 (vs. industry ~31–35) P/B: ~3.1–3.5 (Book Value ~₹168–175) ROE: ~7.5–9% (low but improving) ROCE: ~8% Debt/Equity: Elevated due to expansion (net debt has grown significantly) Dividend Yield: ~0.37–0.42% Recent Performance: Strong revenue growth (TTM … Read more

Marksans Pharma Ltd. (NSE: MARKSANS) – Bullish & Bearish Analysis with Fundamental Screener

by
Marksans pharma

Company Overview Marksans Pharma Ltd. (NSE: MARKSANS) is a fast-growing Indian pharmaceutical company focused on generic formulations, OTC (over-the-counter) medicines, and prescription products. The company derives a large share of its revenue from regulated markets such as the UK, US, Australia, and Europe, while steadily expanding into new international markets. Recent FY2026 results marked the … Read more

Glenmark Pharmaceuticals Ltd. (NSE: GLENMARK) – Bullish & Bearish Analysis with Fundamental Screener

by
Glenmark Pharma

Company Overview Glenmark Pharmaceuticals Ltd. (NSE: GLENMARK) is a leading Indian pharmaceutical company with a diversified portfolio across branded formulations, generics, specialty medicines, and active pharmaceutical ingredients (APIs). The company has a strong presence in India, the US, Europe, Latin America, and emerging markets. Glenmark is also investing in respiratory, dermatology, oncology, and innovative drug … Read more